Track: Cancer Genomics and Epidemiology

The session "Cancer Genomics and Epidemiology" will explore the intersection of genetic research and epidemiological studies in understanding and combating cancer. This session will provide an in-depth look at how the latest advancements in genomics are reshaping our knowledge of cancer's origins, progression, and prevention, offering new avenues for personalized treatment and public health strategies.

Oncogenesis will delve into the genetic changes that drive oncogenesis, including the role of mutations, gene amplification, and chromosomal rearrangements.

Genomic Heterogeneity and Tumors will discuss how advances in genomic sequencing and profiling are uncovering this heterogeneity and guiding the development of precision medicine approaches that target the unique genetic landscape of each patient’s tumor.

Genomic Mutations and Profiling will cover the latest techniques in genomic profiling, including next-generation sequencing, and discuss how these tools are being used to develop personalized treatment strategies.

Liquid Biopsy is an invasive technique for early cancer detection and highlights the latest developments in liquid biopsy technology and its potential to transform cancer care.

Immunogenomics field is critical in the development of immunotherapies, which harness the power of the immune system to fight cancer.

Cancer Surveillance and Prevention Strategies category will discuss how genomic data is being integrated into cancer surveillance programs, to track cancer incidence, and develop targeted prevention strategies.

Genomic Data Integration goal is to create comprehensive genomic databases that can be used to drive research and improve patient outcomes worldwide and explore the challenges and opportunities in leveraging big data for cancer research.

4th International Conference on Cancer Science and Therapy

Track: Cancer Genomics and Epidemiology

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at